NCT01518920View on ClinicalTrials.gov

A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Hearing Loss, Sensorineural
Interventions
DRUG

PF-04958242

PF-04958242 0.35 mg oral solution

DRUG

PF-04958242

PF-04958242 0.27 mg oral solution

DRUG

Placebo

Placebo oral solution

Trial Locations (11)

21287

Pfizer Investigational Site, Baltimore

33143

Pfizer Investigational Site, South Miami

92801

Pfizer Investigational Site, Anaheim

06510

Pfizer Investigational Site, New Haven

06511

Pfizer Investigational Site, New Haven

06519

Pfizer Investigational Site, New Haven

06520-8071

Pfizer Investigational Site, New Haven

75390-8575

Pfizer Investigational Site, Dallas

75390-8868

Pfizer Investigational Site, Dallas

75390-8891

Pfizer Investigational Site, Dallas

75390-9035

Pfizer Investigational Site, Dallas

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY